A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

BACKGROUND: Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (Monofer®) and oral iron in NDD-CKD patient...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Nephrol Dial Transplant
Hoofdauteurs: Kalra, Philip A., Bhandari, Sunil, Saxena, Sanjiv, Agarwal, Dhananjai, Wirtz, Georg, Kletzmayr, Josef, Thomsen, Lars L., Coyne, Daniel W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
CLINICAL SCIENCE
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4805129/
https://ncbi.nlm.nih.gov/pubmed/26250435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv293
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items